Kiran Mazumdar-Shaw, head of Biocon, says the "easy substitution" that generics firms enjoy at the pharmacy does not work with complex biosimilars—which require a doctor's approval to dispense.

百康公司总裁基朗妈祖达尔-萧说非专利药品企业享受在制药业内享受的“简单取代策略”在复杂的生物仿制制药领域将不凑效了---在生物仿制制药领域，需要有医生的批准才可以进行。

youdao

The deal will bolster revenue as Kiran Mazumdar-Shaw, Biocon's ambitious boss, continues to invest in new biotech drugs.

ECONOMIST: The drugs industry

Kiran Mazumdar-Shaw started one of India's first biotech companies, Biocon (otcbb: BCLTF - news - people ).

FORBES: India's Most Powerful Businesswomen

This year's seven dropouts include India's richest self-made woman, Kiran Mazumdar-Shaw.

FORBES: India's 40 Richest